CC
SABS icon

Commodore Capital’s SAB Biotherapeutics SABS Stock Holding History

Commodore Capital’s Portfolio SABS Stock Details SABS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-183,174
Closed -$832K – 41
2024
Q1 		$832K Sell
183,174
-1
-0% -$5 0.06% 38
2023
Q4 		$1.26M Buy
+183,175
New +$1.26M 0.11% 31